Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine resistance in breast cancer
Tumor hypoxia is associated with poor patient outcomes in estrogen receptor-α (ERα) positive breast cancer. Hypoxia is known to affect tumor growth by reprogramming metabolism and regulating amino acid (AA) uptake. Here we show that the glutamine transporter, SNAT2, is the AA transporter most freque...
Váldodahkkit: | Morotti, M, Bridges, E, Valli, A, Choudhry, H, Sheldon, H, Wigfield, S, Gray, N, Zois, C, Grimm, F, Jones, D, Teoh, EJ, Wei-Chen, C, Anastasiou, D, Haider, S, McIntyre, A, Goberdhan, DCI, Buffa, F, Harris, AL, Lord, SR |
---|---|
Materiálatiipa: | Journal article |
Almmustuhtton: |
National Academy of Sciences
2019
|
Geahča maid
-
Increased expression of glutamine transporter SNAT2/SLC38A2 promotes glutamine dependence and oxidative stress resistance, and is associated with worse prognosis in triple-negative breast cancer
Dahkki: Morotti, M, et al.
Almmustuhtton: (2020) -
PATs and SNATs: Amino acid sensors in disguise
Dahkki: Fan, S, et al.
Almmustuhtton: (2018) -
PATs and SNATs: Amino Acid Sensors in Disguise
Dahkki: Shih-Jung Fan, et al.
Almmustuhtton: (2018-06-01) -
Fluciclovine is a potential imaging biomarker of glutamine utilisation in breast cancer
Dahkki: Teoh, EJ, et al.
Almmustuhtton: (2017) -
Fluciclovine (F-18) is a marker for high-affinity glutamine transporter ASCT2-mediated amino acid transport in breast cancer
Dahkki: Teoh, E, et al.
Almmustuhtton: (2017)